- Diversified sales accounted for 55% of total revenue, with a 13% year-over-year increase driven by organic growth and the SyQwest acquisition.
- Medical end market sales increased 8%, with strong growth in therapeutics (+60%) and wins in ultrasound applications.
- Aerospace and Defense sales surged 34%, excluding SyQwest, with a focus on moving from component supplier to sensor and transducer provider.
- Industrial market showed a gradual recovery with a 6% increase from the previous year, driven by wins in EMC, switches, and EV charging applications.
- The company emphasizes its diversification strategy to sustain growth amid market uncertainties.
Related items and other data are not available for this feed item.
Dafinchi